Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma

BACKGROUND: The safety of systemic thrombolysis in patients with intracranial tumor and cavernoma are unknown. So far evidence is limited to a number of case reports and few case series or unspecified data based on population-based analysis. Our aim was to comprehend the risk of systemic thrombolysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarzbach, Christopher Jan, Ebert, Anne, Hennerici, Michael G., Neumaier-Probst, Eva, Platten, Michael, Fatar, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Special Collection: Neuro-oncology: Practice-Changing Developments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808960/
https://www.ncbi.nlm.nih.gov/pubmed/29449886
http://dx.doi.org/10.1177/1756285617753423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808960/
https://www.ncbi.nlm.nih.gov/pubmed/29449886
http://dx.doi.org/10.1177/1756285617753423

Ejemplares similares